Ductal carcinoma in situ (DCIS) of the breast is the earliest detectable form of breast cancer.
Mainstay of treatment is complete surgical removal with or without adjuvant radiotherapy …

Ductal carcinoma in situ (DCIS) is a non-obligate precursor, non-invasive malignancy
confined within the basement membrane of the breast ductal system. There is a wide …

Abstract Purpose of Review Standard options for the treatment of ductal carcinoma in situ
(DCIS) include breast-conserving surgery (BCS) alone; BCS with radiotherapy or endocrine …

Ductal carcinoma in situ (DCIS) represents a unique entity in the spectrum of breast lesions.
With the widespread use of screening mammography, the incidence of DCIS has …

Background Staging of the axilla in women with ductal carcinoma in situ (DCIS) is a point of
controversy. We aimed to assess whether there is a group of patients in whom axillary …

1595 Background: Sentinel node biopsy is frequently performed for patients with
preoperative diagnosis of ductal carcinoma in situ (DCIS) by needle biopsy because of a …

Background Controversy continues regarding the use of adjuvant radiation therapy (RT) and
hormonal therapy (HT) for patients undergoing breast-conserving therapy (BCT) for ductal …

Purpose To spare DCIS patients from overtreatment, treatment de-escalated over the years.
This study evaluates the influence of these developments on the patterns of care in the …

BACKGROUND: Increased use of breast cancer screening has led to an increase in the
number of diagnosed cases of ductal carcinoma in situ (DCIS). However, there is no definite …

Nonsurgical management of ductal carcinoma in situ is controversial and little is known
about the long-term consequences of this approach. In this study, we aimed to determine the …